Does Venous pCO2 Increase by 20 mmHg or More During Apnea Challenge Test?

Sponsor
MemorialCare Health System (Other)
Overall Status
Unknown status
CT.gov ID
NCT02503813
Collaborator
(none)
20
1
1
24
0.8

Study Details

Study Description

Brief Summary

One required examination for declaration of death by neurological criteria is the apnea challenge test. The apnea challenge test evaluates the medulla brainstem respiratory center response to a rise in CO2. The current guideline requires arterial sampling of CO2 and therefore either arterial puncture or arterial catheter placement for the examination. Arterial catheter is an invasive monitoring device and is not without complications. Recent studies have demonstrated that there is a direct correlation between peripheral venous and arterial blood gas measures and that peripheral venous CO2 measures may be used as alternatives to arterial CO2 measure.The purpose of this study is to evaluate brainstem response during the apnea challenge test to a rise in venous CO2 and correlate it with the rise in arterial measured CO2. The objective of this study is to demonstrate a similar rise between the venous and arterial CO2 during the apnea challenge test and eliminate the necessity of arterial blood sampling for the sole purpose of apnea challenge test in the future.

Condition or Disease Intervention/Treatment Phase
  • Procedure: venous blood gas
Early Phase 1

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Does Venous pCO2 Increase by 20 mmHg or More During Apnea Challenge Test?
Study Start Date :
Jul 1, 2015
Anticipated Primary Completion Date :
Jul 1, 2017
Anticipated Study Completion Date :
Jul 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental

Venous blood gas will be obtained at the same time points as arterial blood gas in the apnea challenge test.

Procedure: venous blood gas
Venous blood gas will be measured at the time of arterial blood gas measurement.

Outcome Measures

Primary Outcome Measures

  1. Change in venous blood CO2 during apnea challenge test [During apnea challenge test]

Secondary Outcome Measures

  1. Change in End Tidal CO2 during apnea challenge test [During apnea challenge test]

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Week and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age > 37 weeks gestation up to any adult age

  2. Patients admitted to Pediatric Intensive Care unit (PICU), Neonatal Intensive Care Unit (NICU), Medical Intensive Care Unit (MICU) and Cardiothoracic Intensive Care Unit (CTICU)

  3. Patients with irreversible brain injury where the attending physician will be performing death by neurological criteria examination as per hospital policy

  4. Presence of arterial catheter or arterial blood sampling during apnea challenge test

  5. Presence of central venous catheter or easily drawing peripheral intravenous catheter

Exclusion Criteria:
  1. Age less or equal to 37 weeks gestation

  2. Inability to perform apnea challenge test as determined by primary physician

  3. Family request for Donation after Cardiac Death (DCD) or withdrawal of Life Sustaining Therapy

  4. Bicarbonate infusion within 30 minutes of apnea challenge test

Contacts and Locations

Locations

Site City State Country Postal Code
1 Long Beach Memorial and Miller Children's & Women's Hospital Long Beach Long Beach California United States 90806

Sponsors and Collaborators

  • MemorialCare Health System

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alireza Fathi, MD, Director of Critical Care Transport, Assoicate Medical Director, PICU, MemorialCare Health System
ClinicalTrials.gov Identifier:
NCT02503813
Other Study ID Numbers:
  • 504-15
First Posted:
Jul 21, 2015
Last Update Posted:
Jul 21, 2015
Last Verified:
Jul 1, 2015
Keywords provided by Alireza Fathi, MD, Director of Critical Care Transport, Assoicate Medical Director, PICU, MemorialCare Health System
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 21, 2015